NICE backs Boehringer's Giotrif

The U.K.'s NICE issued Giotrif afatinib from Boehringer Ingelheim GmbH (Ingelheim, Germany) to treat locally advanced or metastatic non-small cell lung cancer (NSCLC) in EGFR mutation-positive patient...